Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study

Critically ill patients with coronavirus disease 2019 (COVID-19) may develop COVID-19-associated pulmonary aspergillosis (CAPA), which impacts their chances of survival. Whether positive bronchoalveolar lavage fluid (BALF) mycological tests can be used as a survival proxy remains unknown. We conduct...

Full description

Bibliographic Details
Main Authors: Bassetti, M. (Author), Bourgeois, M. (Author), Cornely, O.A (Author), Dettori, S. (Author), ECMM-CAPA Study Group (Author), Feys, S. (Author), Giacobbe, D.R (Author), Hoenigl, M. (Author), Klimko, N. (Author), Koehler, P. (Author), Lagrou, K. (Author), Lormans, P. (Author), Maertens, J. (Author), Prattes, J. (Author), Rautemaa-Richardson, R. (Author), Reynders, M. (Author), Rutsaert, L. (Author), Salmanton-García, J. (Author), Shadrivova, O. (Author), Signori, A. (Author), Van Regenmortel, N. (Author), Wauters, J. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
GM
Online Access:View Fulltext in Publisher